Critically Ill patients with 2009 influenza A(H1N1) in Mexico.
By G. Dominguez-Cherit, S. Lapinsky, A. Macías, Ruxandra Pinto, Lourdes Espinosa-Pérez, Alethse de la Torre, Manuel Poblano-Morales, J. A. Baltazar-Torres, Edgar Bautista, A. Martinez and 7 more. Journal of the American Medical Association (JAMA), 2009
859 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology
View Paper: https://www.semanticscholar.org/paper/05138f0b3ac5a006de1c253b90b0be276c162485
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Fiore
- L. Gubareva
- D. Shay
- J. Bresee
- T. Uyeki
Citations in the corpus
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis (2011, neutral): “Subsequent studies in several countries, including the US, Mexico, Canada, Spain, Greece, France, Australia, and New Zealand, reported high proportions of obesity among ICU admissions and fatal cases [13,20,58,64,72–77].”
- Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011, background): “Earlier neuraminidase inhibitor treatment was associated with less severe disease, and any neuraminidase inhibitor treatment had a survival benefit in observational studies of patients hospitalized with 2009 H1N1 virus infection (6,12,65,153,154).”